Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven day supply, except in certain circumstances.
Impact
If enacted, A3342 will fundamentally alter how opioid prescriptions are managed within New Jersey. Practitioners will be required to document detailed patient histories, including any history of substance abuse, and to engage in thorough examinations before prescribing opioids. They will also need to develop individualized treatment plans and access state prescription monitoring databases to ensure that prescriptions are issued judiciously. This legislation seeks to strike a balance between providing necessary pain relief while minimizing the potential for addiction and diversion of opioid medications.
Summary
Assembly Bill A3342, sponsored by Assemblyman Paul Kanitra, proposes important amendments to the existing regulations surrounding opioid prescriptions in New Jersey. The bill aims to limit the quantity of opioid medications that healthcare practitioners can prescribe to a maximum of seven days for the treatment of acute pain. This reduction in the supply is designed to mitigate the risks associated with opioid misuse and addiction, a significant issue in public health. The seven-day limit replaces a prior five-day limit, allowing for more flexibility under certain medical circumstances, while still emphasizing the need for responsible prescribing practices.
Contention
The bill reflects a growing consensus on the need for stricter controls on opioid prescriptions to combat the opioid crisis. However, it may draw criticism from certain physician groups who argue that the limitations could hinder their ability to adequately manage patients' pain, particularly in cases requiring longer-term opioid therapy. Opponents may voice concerns that such restrictions could lead to patients experiencing unnecessary pain or having their pain management undermined, especially for those who genuinely require opioids for chronic conditions. As the discussion continues, the potential need for amendments to the bill could focus on addressing the concerns of these practitioners while reinforcing the primary goal of safeguarding public health.
Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven-day supply, except in certain circumstances.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Authorizes visiting advanced practice nurses who are not certified by endorsement in New Jersey to engage in the limited practice of prescribing medications and devices, if they have appropriate educational qualifications.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.